Endovascular Treatment of Cerebrovascular Lesions Using Nickel- or Nitinol-Containing Devices in Patients with Nickel Allergies.
Journal
AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
received:
16
09
2022
accepted:
11
06
2023
pmc-release:
01
08
2024
medline:
11
8
2023
pubmed:
21
7
2023
entrez:
20
7
2023
Statut:
ppublish
Résumé
Nickel is used in many cerebral endovascular treatment devices. However, nickel hypersensitivity is the most common metal allergy, and the relative risk of treatment in these patients is unknown. This retrospective analysis identified patients with nickel or metal allergies who underwent cerebral endovascular treatment with nickel-containing devices. Seven patients with nickel and/or other metal allergies underwent treatment with 9 nickel-containing devices. None experienced periprocedural complications. No patient received treatment with corticosteroids or antihistamines. At a mean clinical follow-up for all patients of 22.8 months (range, 10.5-38.0 months), no patients had symptoms attributable to nickel allergic reactions. The mean radiographic follow-up for all patients at 18.4 months (range, 2.5-37.5 months) showed successful treatment of the targeted vascular pathologies, with no evidence of in-stent stenosis or other allergic or hypersensitivity sequelae. The treatment of cerebrovascular lesions with a nickel-containing device resulted in no adverse outcomes among these patients and was safe and effective.
Identifiants
pubmed: 37474263
pii: ajnr.A7936
doi: 10.3174/ajnr.A7936
pmc: PMC10411833
doi:
Substances chimiques
nitinol
2EWL73IJ7F
Nickel
7OV03QG267
Alloys
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
939-942Informations de copyright
© 2023 by American Journal of Neuroradiology.
Références
World Neurosurg. 2016 Sep;93:271-8
pubmed: 27312391
Chem Res Toxicol. 2010 Feb 15;23(2):309-18
pubmed: 19831422
Lancet. 2000 Dec 2;356(9245):1895-7
pubmed: 11130387
World Neurosurg. 2018 Jul;115:147-153
pubmed: 29684517
J Neurointerv Surg. 2020 May;12(5):521-525
pubmed: 31653756
World Neurosurg. 2018 Dec;120:349-351
pubmed: 30240853
Ann Dermatol. 2012 Nov;24(4):426-9
pubmed: 23197908
Tohoku J Exp Med. 2005 Jul;206(3):243-6
pubmed: 15942152
Contact Dermatitis. 2007 Nov;57(5):287-99
pubmed: 17937743
Neurosurgery. 2011 Oct;69(4):908-13; discussion 913-4
pubmed: 21670718
AJNR Am J Neuroradiol. 2012 Aug;33(7):1225-31
pubmed: 22678845
Circ Cardiovasc Interv. 2012 Apr;5(2):220-6
pubmed: 22456027
Int J Cardiol. 2005 Oct 10;104(3):319-25
pubmed: 16186063
J Neurointerv Surg. 2022 Dec;14(12):1286-1287
pubmed: 35236768
World Neurosurg. 2019 Mar;123:e180-e185
pubmed: 30476671
J Neurointerv Surg. 2017 Dec;9(12):1243-1247
pubmed: 28062804
J Neurointerv Surg. 2022 Dec;14(12):1287-1288
pubmed: 35236769
N Engl J Med. 1993 Nov 18;329(21):1583-4
pubmed: 8413491
Neuroradiology. 2012 Aug;54(8):897-9
pubmed: 22653481
J Neurointerv Surg. 2022 Dec;14(12):1244-1247
pubmed: 34987071
J Neurointerv Surg. 2018 Jan;10(1):e1
pubmed: 28235953
Neuroradiology. 2016 Sep;58(9):877-85
pubmed: 27216205
Neurology. 2015 Jan 6;84(1):97-9
pubmed: 25428692
J Dermatol. 2017 Oct;44(10):1187-1188
pubmed: 27786381
Heart. 2022 Oct 13;108(21):1707-1715
pubmed: 34702756
J Am Acad Orthop Surg Glob Res Rev. 2019 Apr 05;3(4):e023
pubmed: 31334475
J Neurointerv Surg. 2022 Apr;14(4):e4
pubmed: 34433645
J Neurointerv Surg. 2011 Mar;3(1):2-4
pubmed: 21990778